The result in phase 2 clinical trials was 24.2% mean body weight reduction at 48 weeks with the 12mg dose, and the first phase 3 TRIUMPH-4 trial reported an average of 28.7% weight loss at 68 weeks
In addition, a 2019 study published in JAMA Network Open suggests that post-menopausal women who habitually take high doses of vitamin B12, especially if they're also taking high doses of vitamin B6, are at higher risk of hip fracture
Emerging incretin-related therapeutics Beyond conventional incretin-based therapies for type 2 diabetes and, more recently, obesity, the development of novel therapeutic agents is progressing rapidly
Gradzielski, R
We also offer other health services, like: Weight loss injections (Mounjaro) Blood pressure checks Private health consultations You dont need to travel far or deal with long NHS waiting lists
Are you giving out free car washes? shouted one man as he drove by the scene